The Virtual Diagnostic Market is valued at 846.95 Million in 2023 and is predicted to reach 2613.20 Million by the year 2031 at a 15.25 CAGR during the forecast period for 2024-2031.
Increasing incidences of chronic health conditions driving the growth of the virtual diagnostics market. In regular diagnosis, sometimes it becomes difficult to diagnose as many consequences, including poor health conditions, lack of physicians and medical staff, increasing the demand for virtual diagnostic. Virtual diagnostic is an effective option to fulfill the need of such diagnostic products. The market growth is attributed to various factors, including increasing awareness for early disease diagnosis and increasing demand for accessible diagnostics.
Advancements in technologies like artificial intelligence and machine learning are expected to create lucrative opportunities in the future. On the other flip side, However, this system is new and involves multiple challenges, including low accuracy within virtual diagnosis and increasing privacy concerns that may restrain the market growth.
The Global virtual diagnostic market is segmented on the basis of diagnosis type, end-users, and region. Based on the base type, the market is divided into gastrointestinal virtual diagnostics market and ophthalmology virtual diagnostics market and cardiology virtual diagnostics market and pathology virtual diagnostics market, and other virtual diagnostics markets. On the basis of end-users, the market is divided into hospitals, specialty clinics, and ambulatory surgical centers, and others (home care and research institutes). Based on region, the market is studied across North America, Asia-Pacific, Europe, and LAMEA. Among that Europe held the largest share of the market, followed by America and the Asia Pacific. On the other hand, North America is expected to dominate the market during the analysis of the forecast period.
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 846.95 Million |
|
Revenue Forecast In 2031 |
USD 2,613.20 Million |
|
Growth Rate CAGR |
CAGR of 15.25% from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Diagnosis Type, By End-User |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
AliveCor Inc., Cardiologs Technologies, CapsoVision, Inc., Eyenuk, Inc., Healthy.io Ltd., hearX IP (Pty) Ltd., Hill-Rom Holdings, Inc., IDx Technologies Inc., Medtronic Plc., Monitored Therapeutics Inc., Olympus Corporation, Phelcom Technologies, ResApp Health Limited, Sight Diagnostics, SkinVision among others. |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Virtual Diagnostic Market Snapshot
Chapter 4. Global Virtual Diagnostic Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Diagnosis Type Estimates & Trend Analysis
5.1. By Diagnosis Type & Market Share, 2023 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Diagnosis Type:
5.2.1. Gastrointestinal Virtual Diagnostics
5.2.2. Ophthalmology Virtual Diagnostics
5.2.3. Cardiology Virtual Diagnostics
5.2.4. Pathology Virtual Diagnostics
5.2.5. Others Virtual Diagnostics
Chapter 6. Market Segmentation 2: By End-User Estimates & Trend Analysis
6.1. By End-User & Market Share, 2023 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By End-User:
6.2.1. Hospitals
6.2.2. Specialty Clinics and Ambulatory Surgical Centers
6.2.3. Others (Homecare and Research Institutes)
Chapter 7. Virtual Diagnostic Market Segmentation 4: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Virtual Diagnostic Market revenue (US$ Million) estimates and forecasts By Diagnosis Type, 2024 - 2031
7.1.2. North America Virtual Diagnostic Market revenue (US$ Million) estimates and forecasts By End-User, 2024 - 2031
7.1.3. North America Virtual Diagnostic Market revenue (US$ Million) estimates and forecasts by country, 2024 - 2031
7.2. Europe
7.2.1. Europe Virtual Diagnostic Market revenue (US$ Million) By Diagnosis Type, 2024 - 2031
7.2.2. Europe Virtual Diagnostic Market revenue (US$ Million) estimates and forecasts By End-User, 2024 - 2031
7.2.3. Europe Virtual Diagnostic Market revenue (US$ Million) by country, 2024 - 2031
7.3. Asia Pacific
7.3.1. Asia Pacific Virtual Diagnostic Market revenue (US$ Million) By Diagnosis Type, 2024 - 2031
7.3.2. Asia Pacific Virtual Diagnostic Market revenue (US$ Million) estimates and forecasts By End-User, 2024 - 2031
7.3.3. Asia Pacific Virtual Diagnostic Market revenue (US$ Million) by country, 2024 - 2031
7.4. Latin America
7.4.1. Latin America Virtual Diagnostic Market revenue (US$ Million) By Diagnosis Type, 2024 - 2031
7.4.2. Latin America Virtual Diagnostic Market revenue (US$ Million) estimates and forecasts By End-User, 2024 - 2031
7.4.3. Latin America Virtual Diagnostic Market revenue (US$ Million) by country, (US$ Million) 2024 - 2031
7.5. Middle East & Africa
7.5.1. Middle East & Africa Virtual Diagnostic Market revenue (US$ Million) By Diagnosis Type, 2024 - 2031
7.5.2. Middle East & Africa Virtual Diagnostic Market revenue (US$ Million) estimates and forecasts By End-User, 2024 - 2031
7.5.3. Middle East & Africa Virtual Diagnostic Market revenue (US$ Million) by country, 2024 - 2031
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. AliveCor Inc.
8.2.2. Cardiologs Technologies
8.2.3. CapsoVision, Inc.
8.2.4. Eyenuk, Inc.
8.2.5. Healthy.io Ltd.
8.2.6. hearX IP (Pty) Ltd.
8.2.7. Hill-Rom Holdings, Inc.
8.2.8. IDx Technologies Inc.
8.2.9. Medtronic Plc.
8.2.10. Monitored Therapeutics Inc.
8.2.11. Olympus Corporation
8.2.12. Phelcom Technologies
8.2.13. ResApp Health Limited
8.2.14. Sight Diagnostics
8.2.15. SkinVision
8.2.16. Other Prominent Players
Global Virtual Diagnostic Market Revenue (US$ Mn) by Diagnosis Type
Global Virtual Diagnostic Market Revenue (US$ Mn) Based on End Users
Global Virtual Diagnostic Market Revenue (US$ Mn) Based on Region
Europe Virtual Diagnostic Market Revenue (US$ Mn) by Country
North America Virtual Diagnostic Market Revenue (US$ Mn) by Country
Asia Pacific Virtual Diagnostic Market Revenue (US$ Mn) by Country
Latin America Virtual Diagnostic Market Revenue (US$ Mn) by Country
Middle East & Africa Virtual Diagnostic Market Revenue (US$ Mn) by Country
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
